EWM
IBB icon

EPG Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

EPG Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Hold
1,175
– – 0.05% 174
2026
Q1 		$198K Sell
1,175
-176
-13% -$30.1K 0.05% 185
2025
Q4 		$228K Hold
1,351
– – 0.06% 180
2025
Q3 		$195K Sell
1,351
-10
-0.7% -$1.36K 0.05% 186
2025
Q2 		$172K Sell
1,361
-77
-5% -$9.45K 0.05% 187
2025
Q1 		$184K Sell
1,438
-75
-5% -$10.2K 0.05% 231
2024
Q4 		$200K Sell
1,513
-68
-4% -$9.56K 0.05% 231
2024
Q3 		$230K Buy
+1,581
New +$229K 0.06% 224
2024
Q2 		– Sell
-2,399
Closed -$320K – 206
2024
Q1 		$329K Hold
2,399
– – 0.08% 206
2023
Q4 		$317K Sell
2,399
-583
-20% -$71.1K 0.08% 197
2023
Q3 		$365K Sell
2,982
-14,214
-83% -$1.81M 0.11% 177
2023
Q2 		$2.18M Sell
17,196
-338
-2% -$43.9K 0.65% 33
2023
Q1 		$2.26M Buy
17,534
+127
+0.7% +$16.6K 0.71% 28
2022
Q4 		$2.29M Buy
17,407
+702
+4% +$90.7K 0.87% 24
2022
Q3 		$1.95M Buy
16,705
+14,869
+810% +$1.85M 0.8% 22
2022
Q2 		$216K Sell
1,836
-356
-16% -$42.3K 0.09% 200
2022
Q1 		$286K Buy
2,192
+418
+24% +$54.4K 0.1% 181
2021
Q4 		$271K Buy
1,774
+8
+0.5% +$1.24K 0.1% 185
2021
Q3 		$286K Sell
1,766
-128
-7% -$21.5K 0.11% 160
2021
Q2 		$310K Sell
1,894
-17,849
-90% -$2.75M 0.13% 148
2021
Q1 		$2.97M Buy
19,743
+632
+3% +$100K 1.45% 12
2020
Q4 		$2.9M Buy
19,111
+486
+3% +$69.5K 1.74% 9
2020
Q3 		$2.52M Buy
18,625
+1,989
+12% +$270K 1.86% 9
2020
Q2 		$2.27M Buy
16,636
+15,392
+1,237% +$1.96M 1.61% 11
2020
Q1 		$134K Buy
1,244
+424
+52% +$48.8K 0.1% 152
2019
Q4 		$99K Buy
+820
New +$91.5K 0.07% 155

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

EPG Wealth Management's IBB Position: Q2 2026 in Review

EPG Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,175 shares worth $223K. The position accounts for 0.05% of the portfolio, ranked #174.

EPG Wealth Management first reported a position in IBB in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.97M in Q1 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • EPG Wealth Management held 1,175 shares of iShares Biotechnology ETF worth $223K as of Q2 2026.
  • EPG Wealth Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.05% of EPG Wealth Management's portfolio in Q2 2026, its #174 holding.
  • EPG Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 26 quarters since.
  • EPG Wealth Management's iShares Biotechnology ETF position peaked at $2.97M in Q1 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on EPG Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.